About this trial
Skin carcinomas are the most commonly diagnosed cancers in fair-skinned populations, for example in France, Western Europe, and North America in particular. The OpticSkin project will build and make available to the general public and the scientific and medical community a histological and optical spectroscopic database of healthy, precancerous, and cancerous human skin in terms of absorption, elastic and inelastic scattering (Raman), steady-state and time-resolved autofluorescence, and polarization. The aim is to identify spectroscopic signatures that will be useful for diagnosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients with skin carcinomas and actinic keratoses
Disqualifiers
minor patient
Trial population
The OpticSkin study will be conducted on paraffin blocks containing skin samples taken from the 140 patients included in the SpectroLive study NCT0295626, ID-RCB: 2016-A00608-43.
Trial design
Case-only
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
automated recognition
automated recognition (by supervised classification) of optical data acquired on different histological classes
Sponsors and contacts
Click on the lead sponsor to view all of their trials.